Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 24-month follow-up:

Multiple Sclerosis Journal – Experimental, Translational and Clinical

Anasua Bandyopadhyay¹  Samuel Cohn²  Thomas E Love³  Carrie M Hersh⁴  Robert A Bermel⁵  Daniel Ontaneda⁵  Robert J Fox⁵  Jeffrey A Cohen⁵  Claire Hara-Cleaver⁵ 

[1] College of Arts and Sciences, 1371Emory University, USA;Department of Neurology, Cleveland Clinic, USA;Departments of Medicine and Epidemiology and Biostatistics, Case Western Reserve University, USA;Lou Ruvo Center for Brain Health, Cleveland Clinic, USA;Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, USA

关键词: Dimethyl fumarate;    fingolimod;    comparative efficacy;    discontinuation;    multiple sclerosis;    propensity score analysis;   

DOI  :  10.1177/2055217317715485

学科分类：医学（综合）

来源: Sage Journals

【 授权许可】

CC BY-NC